Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 71

1.

Simplified LC/MS assay for the measurement of isolevuglandin protein adducts in plasma and tissue samples.

Yermalitsky VN, Matafonova E, Tallman K, Li Z, Zackert W, Roberts LJ 2nd, Amarnath V, Davies SS.

Anal Biochem. 2018 Nov 17;566:89-101. doi: 10.1016/j.ab.2018.11.007. [Epub ahead of print]

PMID:
30458125
2.

Isolevuglandins and cardiovascular disease.

Davies SS, May-Zhang LS.

Prostaglandins Other Lipid Mediat. 2018 Nov;139:29-35. doi: 10.1016/j.prostaglandins.2018.10.002. Epub 2018 Oct 5. Review.

PMID:
30296489
3.

Modification by isolevuglandins, highly reactive γ-ketoaldehydes, deleteriously alters high-density lipoprotein structure and function.

May-Zhang LS, Yermalitsky V, Huang J, Pleasent T, Borja MS, Oda MN, Jerome WG, Yancey PG, Linton MF, Davies SS.

J Biol Chem. 2018 Jun 15;293(24):9176-9187. doi: 10.1074/jbc.RA117.001099. Epub 2018 Apr 30.

PMID:
29712723
4.

Dietary Fatty Acids Control the Species of N-Acyl-Phosphatidylethanolamines Synthesized by Therapeutically Modified Bacteria in the Intestinal Tract.

Dosoky NS, Guo L, Chen Z, Feigley AV, Davies SS.

ACS Infect Dis. 2018 Jan 12;4(1):3-13. doi: 10.1021/acsinfecdis.7b00127. Epub 2017 Oct 17.

PMID:
29019649
5.

Reactive Carbonyl Species Scavengers-Novel Therapeutic Approaches for Chronic Diseases.

Davies SS, Zhang LS.

Curr Pharmacol Rep. 2017 Apr;3(2):51-67. doi: 10.1007/s40495-017-0081-6. Epub 2017 Feb 14.

6.

Leptogenic effects of NAPE require activity of NAPE-hydrolyzing phospholipase D.

Chen Z, Zhang Y, Guo L, Dosoky N, de Ferra L, Peters S, Niswender KD, Davies SS.

J Lipid Res. 2017 Aug;58(8):1624-1635. doi: 10.1194/jlr.M076513. Epub 2017 Jun 8.

7.

Net cholesterol efflux capacity of HDL enriched serum and coronary atherosclerosis in rheumatoid arthritis.

Ormseth MJ, Yancey PG, Yamamoto S, Oeser AM, Gebretsadik T, Shintani A, Linton MF, Fazio S, Davies SS, Roberts LJ 2nd, Vickers KC, Raggi P, Kon V, Stein CM.

IJC Metab Endocr. 2016 Dec;13:6-11. doi: 10.1016/j.ijcme.2016.08.002. Epub 2016 Aug 28.

8.

Isolevuglandins as a gauge of lipid peroxidation in human tumors.

Yan HP, Roberts LJ, Davies SS, Pohlmann P, Parl FF, Estes S, Maeng J, Parker B, Mernaugh R.

Free Radic Biol Med. 2017 May;106:62-68. doi: 10.1016/j.freeradbiomed.2017.02.020. Epub 2017 Feb 9.

9.

Dendritic cells and isolevuglandins in immunity, inflammation, and hypertension.

Dixon KB, Davies SS, Kirabo A.

Am J Physiol Heart Circ Physiol. 2017 Mar 1;312(3):H368-H374. doi: 10.1152/ajpheart.00603.2016. Epub 2016 Dec 16. Review.

10.

Reactive gamma-ketoaldehydes as novel activators of hepatic stellate cells in vitro.

Longato L, Andreola F, Davies SS, Roberts JL, Fusai G, Pinzani M, Moore K, Rombouts K.

Free Radic Biol Med. 2017 Jan;102:162-173. doi: 10.1016/j.freeradbiomed.2016.11.036. Epub 2016 Nov 24.

PMID:
27890721
11.

Accumulation of isolevuglandin-modified protein in normal and fibrotic lung.

Mont S, Davies SS, Roberts Second LJ, Mernaugh RL, McDonald WH, Segal BH, Zackert W, Kropski JA, Blackwell TS, Sekhar KR, Galligan JJ, Massion PP, Marnett LJ, Travis EL, Freeman ML.

Sci Rep. 2016 Apr 27;6:24919. doi: 10.1038/srep24919.

12.

Microbial metabolism of dietary components to bioactive metabolites: opportunities for new therapeutic interventions.

Zhang LS, Davies SS.

Genome Med. 2016 Apr 21;8(1):46. doi: 10.1186/s13073-016-0296-x. Review.

13.

Immune activation caused by vascular oxidation promotes fibrosis and hypertension.

Wu J, Saleh MA, Kirabo A, Itani HA, Montaniel KR, Xiao L, Chen W, Mernaugh RL, Cai H, Bernstein KE, Goronzy JJ, Weyand CM, Curci JA, Barbaro NR, Moreno H, Davies SS, Roberts LJ 2nd, Madhur MS, Harrison DG.

J Clin Invest. 2016 Apr 1;126(4):1607. doi: 10.1172/JCI87425. Epub 2016 Apr 1. No abstract available.

14.

Effect of Drug Therapy on Net Cholesterol Efflux Capacity of High-Density Lipoprotein-Enriched Serum in Rheumatoid Arthritis.

Ormseth MJ, Yancey PG, Solus JF, Bridges SL Jr, Curtis JR, Linton MF, Fazio S, Davies SS, Roberts LJ 2nd, Vickers KC, Kon V, Michael Stein C; TETRAD Investigators.

Arthritis Rheumatol. 2016 Sep;68(9):2099-105. doi: 10.1002/art.39675.

15.

The Role of Lipids and Lipoproteins in Atherosclerosis.

Linton MF, Yancey PG, Davies SS, Jerome WGJ, Linton EF, Vickers KC.

In: De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, editors. Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc.; 2000-.
2015 Dec 24.

16.

Corynebacterium accolens Releases Antipneumococcal Free Fatty Acids from Human Nostril and Skin Surface Triacylglycerols.

Bomar L, Brugger SD, Yost BH, Davies SS, Lemon KP.

MBio. 2016 Jan 5;7(1):e01725-15. doi: 10.1128/mBio.01725-15.

17.

Immune activation caused by vascular oxidation promotes fibrosis and hypertension.

Wu J, Saleh MA, Kirabo A, Itani HA, Montaniel KR, Xiao L, Chen W, Mernaugh RL, Cai H, Bernstein KE, Goronzy JJ, Weyand CM, Curci JA, Barbaro NR, Moreno H, Davies SS, Roberts LJ 2nd, Madhur MS, Harrison DG.

J Clin Invest. 2016 Jan;126(1):50-67. doi: 10.1172/JCI80761. Epub 2015 Nov 23. Erratum in: J Clin Invest. 2016 Apr 1;126(4):1607.

18.

Clinical Relevance of Biomarkers of Oxidative Stress.

Frijhoff J, Winyard PG, Zarkovic N, Davies SS, Stocker R, Cheng D, Knight AR, Taylor EL, Oettrich J, Ruskovska T, Gasparovic AC, Cuadrado A, Weber D, Poulsen HE, Grune T, Schmidt HH, Ghezzi P.

Antioxid Redox Signal. 2015 Nov 10;23(14):1144-70. doi: 10.1089/ars.2015.6317. Epub 2015 Oct 26. Review.

19.

Isolevuglandin-type lipid aldehydes induce the inflammatory response of macrophages by modifying phosphatidylethanolamines and activating the receptor for advanced glycation endproducts.

Guo L, Chen Z, Amarnath V, Yancey PG, Van Lenten BJ, Savage JR, Fazio S, Linton MF, Davies SS.

Antioxid Redox Signal. 2015 Jun 20;22(18):1633-45. doi: 10.1089/ars.2014.6078. Epub 2015 Mar 18.

20.

Reactive γ-ketoaldehydes promote protein misfolding and preamyloid oligomer formation in rapidly-activated atrial cells.

Sidorova TN, Yermalitskaya LV, Mace LC, Wells KS, Boutaud O, Prinsen JK, Davies SS, Roberts LJ 2nd, Dikalov SI, Glabe CG, Amarnath V, Barnett JV, Murray KT.

J Mol Cell Cardiol. 2015 Feb;79:295-302. doi: 10.1016/j.yjmcc.2014.11.013. Epub 2014 Nov 18.

Supplemental Content

Loading ...
Support Center